When activated, the GLP-1 receptor causes multiple biological effects, such as reducing neuroinflammation, promoting nerve growth, improving heart function by improving microvascular function and reducing cardiovascular events by decreasing blood pressure, suppressing appetite, delaying gastric emptying, regulating blood lipid metabolism, and reducing fat deposition as well as activating the metabolism of brown fat
We refer to a recent systematic review and meta-analysis for details regarding the effects of GLP-1 receptor agonists on cardiovascular outcomes [8]
Description Tesamorelin Research Grade GHRH Analog Peptide Tesamorelin is a synthetic growth hormone-releasing hormone analog research peptide supplied for laboratory, analytical, and controlled research environments
Cardiovascular Outcomes and Clinical Trial Data One of the most reassuring findings is that cardiovascular outcome data remain strongly favorable despite small increases in resting heart rate